Deutsche Bank analyst Pito Chickering raised the firm’s price target on Tenet Healthcare to $155 from $150 and keeps a Buy rating on the shares. While the 83% year-to-date rally in the shares results in concerns around expectations into earnings and a potential pullback, Deutsche continues to see “substantial upside to numbers,” the analyst tells investors in a research note. The firm still sees “ample room” for Tenet’s multiple to expand from current levels.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet Healthcare price target raised to $150 from $126 at Deutsche Bank
- Tenet Healthcare price target raised to $140 from $107 at JPMorgan
- Tenet Healthcare initiated with an Outperform at Baird
- Tenet call volume above normal and directionally bullish
- Tenet Healthcare price target raised to $147 from $113 at Barclays